Dextrose
Injection
Current
FDA shortage record
- Substance
- Dextrose
- Manufacturer
- ICU Medical Inc.
- Dosage form
- Injection
- Presentation
- DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19)
- Route(s)
- INTRAVENOUS
- Therapeutic category
- Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
- Package NDC
0990-7918-19- Initially posted
- 10/11/2024
- Current FDA status
- Current
Reason and context
Reason reported: Other
On allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7918-19
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 1-866-829-9025 or ProductAvailability@icumed.com.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
b5cb7a5a-bbe8-4217-a82e-da818f7771c9). - FDA UNII identifier:
LX22YL083G. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.